Claritin-D Litigation Settlement Reached Between Schering, Andrx
This article was originally published in The Tan Sheet
Executive Summary
Litigation related to Impax Laboratories' generic version of Schering-Plough's Claritin-D OTC allergy drug is the last pending patent dispute involving the D formulation following a settlement with Andrx